A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/55 (2006.01) A61K 31/27 (2006.01) A61K 31/366 (2006.01) A61K 31/4015 (2006.01) A61K 31/407 (2006.01) A61K 31/4406 (2006.01) A61K 31/4706 (2006.01) A61K 31/662 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2535613
The present invention is concerned with treatment of sleep disorders by administering a cholinesterase inhibitor, and in particular, by administering galantamine or a pharmaceutically acceptable salt thereof. Also in particular, cholinesterase inhibitors that are active at nicotinic receptors and that are selective for acetylcholinesterase over butylcholinesterase are used in treating sleep disorders.
L'invention concerne le traitement de troubles du sommeil par administration d'un inhibiteur de la cholinestérase, et en particulier, par administration d'une galantamine ou d'un sel de celle-ci pharmaceutiquement acceptable. Les inhibiteurs de la cholinestérase qui sont, en particulier, actifs au niveau des récepteurs nicotiniques et sélectifs pour une acétylcholinestérase par rapport à une butylcholinestérase sont utilisés pour traiter des troubles du sommeil.
Janssen Pharmaceutica N.v.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Treatment of sleep disorders with cholinesterase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of sleep disorders with cholinesterase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of sleep disorders with cholinesterase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1412979